Clinical trial
Can Electroconvulsive Therapy Alter Retinal Nerve Fiber Layer Thickness of Patients With Depression
NCT04305132 is registered in ClinicalTrials.gov with Mehmet Diyaddin Güleken as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Electroconvulsive Therapy Alter Retinal Nerve Fiber Layer Thickness of Patients With Depression
- Lead sponsor
- Mehmet Diyaddin Güleken
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2020
- Completion date
- September 30, 2021
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression